Table 1.
Baseline characteristics for all patients with GBM.
| Characteristics | No. of patients (%) |
|---|---|
| Age (years) | |
| Mean ±SD | 47.1 ± 11.6 |
| Gender | |
| Male | 41 (61.2) |
| Female | 26 (38.8) |
| Tumor location | |
| 1 lobe | 23 (34.3) |
| 2 lobes | 28 (41.8) |
| 3 lobes | 12 (17.9) |
| 4 lobes | 4 (6.0) |
| Tumor size (cm) | |
| Mean ±SD | 5.1 ± 1.5 |
| KPS score | |
| Median (range) | 80 (30–90) |
| Extent of resection | |
| GTR | 49 (73.1) |
| NTR | 13 (19.4) |
| STR | 5 (7.5) |
| Chemotherapy | |
| Yes | 60 (89.6) |
| Radiotherapy | |
| Yes | 60 (89.6) |
| 1p/19q codeletion | |
| Yes | 0 (0.0) |
| IDH mutation | |
| Yes | 6 (9.0) |
| MGMT methylation | |
| Yes | 35 (52.2) |
SD, standard deviation; KPS, Karnofsky performance scale; GTR, gross-total resection; NTR, near-total resection; STR, subtotal resection; IDH, isocitrate dehydrogenase; MGMT, O6-methylguanine-DNA-methyltransferase.